Profile data is unavailable for this security.
About the company
Eyenovia, Inc. is a commercial-stage ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics based on its Optejet platform. It is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.
- Revenue in USD (TTM)3.79k
- Net income in USD-27.26m
- Incorporated2014
- Employees57.00
- LocationEyenovia Inc295 Madison Ave Ste 2400NEW YORK 10017United StatesUSA
- Phone+1 (813) 766-9539
- Fax+1 (302) 636-5454
- Websitehttps://eyenovia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immuneering Corp | 0.00 | -53.47m | 48.63m | 68.00 | -- | 0.530 | -- | -- | -1.89 | -1.89 | 0.00 | 3.09 | 0.00 | -- | -- | 0.00 | -47.54 | -- | -51.16 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -5.86 | -- | -- | -- |
Ocuphire Pharma Inc | 19.05m | -9.99m | 49.38m | 14.00 | -- | 0.9561 | -- | 2.59 | -0.4735 | -0.4735 | 0.8727 | 2.08 | 0.3701 | -- | 5.30 | 1,360,643.00 | -19.40 | -58.31 | -20.77 | -65.94 | -- | -- | -52.42 | -137.92 | -- | -8.46 | 0.00 | -- | -52.20 | -- | -155.83 | -- | -- | -- |
Modular Medical Inc | 0.00 | -16.76m | 49.89m | 37.00 | -- | 8.92 | -- | -- | -0.9653 | -0.9653 | 0.00 | 0.1805 | 0.00 | -- | -- | 0.00 | -224.40 | -168.16 | -262.22 | -209.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 25.51 | -- | 154.53 | -- |
Odonate Inc | 0.00 | -102.07m | 50.02m | 137.00 | -- | 1,844.41 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
Correlate Energy Corp | 7.56m | -12.79m | 50.15m | 19.00 | -- | -- | -- | 6.63 | -0.3554 | -0.3554 | 0.21 | -0.0877 | 2.22 | -- | 13.19 | 398,051.60 | -375.16 | -315.47 | -- | -- | 18.27 | 15.42 | -169.09 | -201.03 | -- | -0.7239 | 8.30 | -- | 122.20 | 46.12 | -78.54 | -- | -- | -- |
Hcw Biologics Inc | 2.84m | -24.99m | 50.31m | 45.00 | -- | 3.56 | -- | 17.70 | -0.6953 | -0.6953 | 0.0791 | 0.3737 | 0.0755 | -- | 2.91 | 63,150.89 | -66.37 | -- | -78.58 | -- | 19.72 | -- | -879.53 | -- | -- | -90.86 | 0.319 | -- | -57.72 | -- | -67.74 | -- | -- | -- |
Ocean Biomedical Holdings Inc | 0.00 | -45.58m | 50.93m | 9.00 | -- | -- | -- | -- | -1.40 | -1.40 | 0.00 | -0.0642 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -612.50 | -- | -- | -- |
Journey Medical Corp | 79.18m | -3.85m | 51.41m | 58.00 | -- | 3.50 | -- | 0.6493 | -0.3502 | -0.3502 | 4.19 | 1.05 | 0.8701 | 2.19 | 3.65 | 1,365,190.00 | -4.23 | -- | -10.51 | -- | 66.33 | -- | -4.87 | -- | 1.10 | 0.6863 | 0.4641 | -- | 7.48 | -- | 87.00 | -- | -- | -- |
Eyenovia Inc | 3.79k | -27.26m | 51.47m | 57.00 | -- | 5.11 | -- | 13,579.80 | -0.6639 | -0.6639 | 0.00009 | 0.1976 | 0.0001 | -- | 0.0031 | 66.49 | -91.15 | -80.31 | -119.11 | -117.70 | 0.00 | -- | -719,290.30 | -680.95 | 2.16 | -15.14 | 0.6135 | -- | -- | -- | 2.68 | -- | 152.20 | -- |
Aadi Bioscience Inc | 24.35m | -65.77m | 52.05m | 74.00 | -- | 0.4948 | -- | 2.14 | -2.44 | -2.44 | 0.9049 | 4.28 | 0.1538 | 0.6779 | 6.63 | 273,640.40 | -41.54 | -50.25 | -48.46 | -56.15 | 88.47 | -- | -270.04 | -473.97 | 4.48 | -- | 0.00 | -- | 60.06 | 3.85 | -8.68 | -- | 153.54 | -- |
Intensity Therapeutics Inc | 0.00 | -11.86m | 52.92m | 5.00 | -- | 4.02 | -- | -- | -0.8653 | -0.8653 | 0.00 | 0.9601 | 0.00 | -- | -- | 0.00 | -110.62 | -- | -254.70 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.45 | -- | -- | -- |
Enzo Biochem Inc | 32.80m | -23.31m | 53.27m | 179.00 | -- | 0.7419 | -- | 1.62 | -0.4699 | 0.6708 | 0.6586 | 1.40 | 0.3738 | 1.61 | 4.10 | 183,257.00 | -26.56 | -12.21 | -39.50 | -15.79 | 42.17 | 37.09 | -71.07 | -18.76 | 2.89 | -- | 0.0476 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
Gain Therapeutics Inc | 55.18k | -22.27m | 53.43m | 29.00 | -- | 3.81 | -- | 968.36 | -1.74 | -1.74 | 0.0042 | 0.7761 | 0.0026 | -- | 0.2544 | 1,902.76 | -104.28 | -- | -132.41 | -- | -- | -- | -40,354.33 | -13,827.07 | -- | -- | 0.0432 | -- | -60.62 | 21.77 | -26.59 | -- | 13.96 | -- |
Holder | Shares | % Held |
---|---|---|
Armistice Capital LLCas of 31 Dec 2023 | 4.38m | 9.24% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 1.52m | 3.21% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 1.37m | 2.90% |
Cowen & Co. LLCas of 31 Mar 2024 | 827.85k | 1.75% |
Geode Capital Management LLCas of 31 Dec 2023 | 639.07k | 1.35% |
Avenue Capital Management II LPas of 31 Dec 2023 | 547.81k | 1.16% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 488.18k | 1.03% |
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 253.25k | 0.53% |
Renaissance Technologies LLCas of 31 Dec 2023 | 243.88k | 0.52% |
BNP Paribas Financial Marketsas of 31 Mar 2024 | 219.61k | 0.46% |